Medifast (MED) Operating Leases (2019 - 2026)

Medifast (MED) has 8 years of Operating Leases data on file, last reported at $12.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 16.63% year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at $12.2 million (down 16.63% YoY), and the FY2025 full-year result was $6.1 million, down 38.74% from the prior year.
• Operating Leases for Q1 2026 stood at $12.2 million, up from $6.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $29.3 million in Q2 2022 and bottomed at $6.1 million in Q4 2025.
• The 5-year median for Operating Leases is $16.1 million (2023), against an average of $16.7 million.
• The widest annual swing landed in 2022, when Operating Leases jumped 269.21%; it then sank 48.45% in 2024.
• A 5-year view of Operating Leases shows it stood at $20.3 million in 2022, then declined by 20.46% to $16.1 million in 2023, then tumbled by 38.35% to $9.9 million in 2024, then plunged by 38.74% to $6.1 million in 2025, then jumped by 99.98% to $12.2 million in 2026.
• The last three Operating Leases figures came in at $12.2 million (Q1 2026), $6.1 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.

Peer Comparison